Abstract: The invention relates to polymer-drug conjugate for delivering a substituted alkanoic acid non-steroidal anti-inflammatory drug (NSAID). The invention also relates to drug delivery systems comprising the polymer-NSAID conjugate. The polymer-NSAID conjugates comprise a substituted alkanoic acid non-steroidal anti-inflammatory drug (NSAID) conjugated to a biodegradable polymer backbone by an ester linkage.

Abstract: Monomers having the structure and a polymer comprising as part of its polymer backbone a moiety of Formula (II): where one of R6 to R10 represents A-O— and one of R6 to R10 represents —O—B and the remainder of R6 to R10 represent H, where A and B represent the remainder of the polymer backbone and may be the same or different.

Abstract: The present invention relates to a polymer comprising as part of its polymer backbone a moiety of Formula (II): where one of R6 to R10 represents A-O— and one of R6 to R10 represents —O—B and the remainder of R6 to R10 represent H, where A and B represent the remainder of the polymer backbone and may be the same or different.

Abstract: A polymer comprising as part of its polymer backbone a cineole-type moiety having a structure according to Formula (II): where one of R6 to R10 represents A-O— and one of R6 to R10 represents —O—B and the remainder of R6 to R10 represent H, where A and B, which may be the same or different, represent the remainder of the polymer backbone and are independently selected from the group consisting of polyurethane, polyester, polyamide, polycarbonate, polyimide, polyether, polyepoxy, polyacrylate, polysiloxane, polyvinyl and combinations thereof. The polymer comprising as part of its polymer backbone a moiety of Formula (II) or polymer blend, comprising this polymer, can be used for production of a sheet, fiber or film.

Abstract: The invention relates to polymer-drug conjugate for delivering a substituted alkanoic acid non-steroidal anti-inflammatory drug (NSAID). The invention also relates to drug delivery systems comprising the polymer-NSAID conjugate. The polymer-NSAID conjugates comprise a substituted alkanoic acid non-steroidal anti-inflammatory drug (NSAID) conjugated to a biodegradable polymer backbone by an ester linkage.

Abstract: The invention relates to a biodegradable polymer comprising a plurality of releasable bioactive moieties, the releasable bioactive moieties being pendant from and covalently bonded to the biodegradable polymer backbone, wherein the biodegradable polymer backbone is formed from monomeric units that are each coupled via a biodegradable moiety, and wherein the bioactive moieties are capable of being released at a rate equal to or faster than the rate of biodegradation of the polymer backbone.

Abstract: The present invention relates to a polyurethane polymer comprising as part of its polymer backbone an ?-oxy carbonyl moiety of general formula (I), where A and B represent the remainder of the polymer backbone and are the same or different, and R is an optionally substituted aliphatic hydrocarbon having three or more carbon atoms.

Abstract: The present invention relates to a polymer comprising as part of its polymer backbone a moiety of Formula (II): where one of R6 to R10 represents A-O— and one of R6 to R10 represents —O—B and the remainder of R6 to R10 represent H, where A and B represent the remainder of the polymer backbone and may be the same or different.

Abstract: The invention relates to a biodegradable polymer comprising a plurality of releasable bioactive moieties, the releasable bioactive moieties being pendant from and covalently bonded to the biodegradable polymer backbone, wherein the biodegradable polymer backbone is formed from monomeric units that are each coupled via a biodegradable moiety, and wherein the bioactive moieties are capable of being released at a rate equal to or faster than the rate of biodegradation of the polymer backbone.

Abstract: The present invention relates to a method of preparing a polymer composition, the method comprising melt mixing an aliphatic condensation polymer with a cyclic ester of general formula (I) where X is an optionally substituted aliphatic hydrocarbon having 2 or more carbon atoms present in the cycle.

Abstract: The present invention relates to enzymes which possess hydroxylase activity, in particular 42 hydroxylase activity, that can be used in methods of synthesizing modified fatty acids.